<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1750289</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2026.1750289</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Porcine cells restrict human cell proliferation via cellular competition in a human-porcine mesenchymal stem cells co-culture model</article-title>
<alt-title alt-title-type="left-running-head">Fan et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2026.1750289">10.3389/fcell.2026.1750289</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Fan</surname>
<given-names>Xinyuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3293677"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>An</surname>
<given-names>Xinglan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing &#x2013; review and editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Tong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing &#x2013; review and editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Ziyi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/634830"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing &#x2013; review and editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Dai</surname>
<given-names>Xiangpeng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1002934"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing &#x2013; review and editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Xiaoling</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1381103"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing &#x2013; review and editing</role>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital, Jilin University</institution>, <city>Changchun</city>, <country country="CN">China</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>National-Local Joint Engineering Laboratory of Animal Models for Human Disease, First Hospital, Jilin University</institution>, <city>Changchun</city>, <country country="CN">China</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Xiangpeng Dai, <email xlink:href="mailto:daixiangpeng@jlu.edu.cn">daixiangpeng@jlu.edu.cn</email>; Xiaoling Zhang, <email xlink:href="mailto:xiaolingzhang@jlu.edu.cn">xiaolingzhang@jlu.edu.cn</email>
</corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-25">
<day>25</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>14</volume>
<elocation-id>1750289</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>05</day>
<month>02</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Fan, An, Zhang, Li, Dai and Zhang.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Fan, An, Zhang, Li, Dai and Zhang</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-25">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The xenotransplantation of human cells into porcine hosts holds immense potential in the fields of regenerative medicine and organ transplantation. However, the low survival rate of human-derived cells within porcine remains a critical bottleneck constraining the application of xenotransplantation. Whether porcine cells exert negative effect on human cell growth is not studied. Here, we established an <italic>in vitro</italic> direct co-culture model of human and porcine mesenchymal stem cells (hMSCs and pMSCs) to investigate the competitive relationship between human and porcine-derived cells. The results demonstrated that the proliferation capability of hMSCs in the co-culture system was significantly suppressed compared to those cultured in isolation. Moreover, an increasing number of pMSCs exhibited enhanced inhibition of hMSC proliferation. Notably, results from transwell assays and treatment with porcine-conditioned medium indicated that the inhibition of hMSCs by pMSCs was not mediated through soluble cytokines. To elucidate the underlying molecular mechanisms, RNA sequencing analysis was performed and the result revealed that direct co-culture significantly downregulated the expression of proliferation-related genes in hMSCs, including <italic>CYP1B1</italic>, <italic>SLC7A11</italic>, <italic>TFAP2C</italic>, and <italic>PSAT1</italic>. Concurrently, the co-culture paradigm disrupted endoplasmic reticulum function and multiple amino acid transport processes within hMSCs, while activating the NF-&#x3ba;B signaling pathway, thereby achieving negative regulation of hMSC proliferation. Collectively, our primary study characterized the competitive interactions between hMSCs and pMSCs and uncovered possible underlying mechanisms which provided new experimental foundations for improving human cell survival in porcine hosts to advance xenotransplantation application.</p>
</abstract>
<kwd-group>
<kwd>cell competition</kwd>
<kwd>human</kwd>
<kwd>mesenchymal stem cells</kwd>
<kwd>porcine</kwd>
<kwd>xenotransplantation</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">
<institution-wrap>
<institution>Natural Science Foundation of Jilin Province</institution>
<institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/100007847</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This work was partially supported by the Natural Science Foundation of Jilin Province (20210204165YY).</funding-statement>
</funding-group>
<counts>
<fig-count count="6"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="45"/>
<page-count count="13"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Embryonic Development</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<label>1</label>
<title>Introduction</title>
<p>Transplantation of human cells into porcine hosts exhibits immense potential in the fields of regenerative medicine and organ transplantation by generating physiologically functional humanized organs in pigs, establishing disease models, and evaluating the safety and efficacy of human cell therapies in porcine hosts (<xref ref-type="bibr" rid="B42">Wu et al., 2017</xref>). However, low human cell transplantation efficiency constrained the generation of humanized organs in pigs which can be clinically used in organ transplantation. Therefore, researchers tried to generate human cell lines with enhanced adaptability by overexpressing the anti-apoptotic gene <italic>BCL2</italic>, the pro-proliferative gene <italic>MYCN</italic>, or by mutating the tumor suppressor gene <italic>TP53</italic> in human cells (<xref ref-type="bibr" rid="B24">Maeng et al., 2021</xref>; <xref ref-type="bibr" rid="B40">Wang et al., 2023</xref>). Notably, the genetically modified cells not only survived and engrafted successfully in pig embryos with organogenesis defects but also contributed to the formation of functional humanized tissues, including endothelial tissue, skeletal muscle tissue, mid-stage renal structures, and cardiac muscle tissue (<xref ref-type="bibr" rid="B9">Das et al., 2020</xref>; <xref ref-type="bibr" rid="B24">Maeng et al., 2021</xref>; <xref ref-type="bibr" rid="B40">Wang et al., 2023</xref>; <xref ref-type="bibr" rid="B25">Mallapaty, 2025</xref>). These results demonstrate that targeted gene editing can effectively improve human cell survival in xenotransplantation settings and offer valuable insights for enhancing transplantation efficiency in future studies.</p>
<p>Importantly, the low survival rate of human cells in porcine hosts may be attributed to immune rejection and interspecies microenvironmental incompatibility. The porcine immune system identifies and attacks implanted human cells, leading to a complex immune rejection process. Moreover, the differences between human and porcine cellular microenvironments encompass three key aspects: interspecies cell competition, impaired intercellular signaling, and the potential risk of infection from porcine endogenous retroviruses (<xref ref-type="bibr" rid="B35">Schuurman et al., 2003</xref>; <xref ref-type="bibr" rid="B28">Niu et al., 2021</xref>; <xref ref-type="bibr" rid="B44">Zheng et al., 2021</xref>; <xref ref-type="bibr" rid="B22">Liu et al., 2023</xref>). Among these, cell competition&#x2014;a widespread homeostatic regulatory mechanism in multicellular organisms&#x2014;is regarded as a key determinant affecting interspecies cellular coexistence. Its primary role is to eliminate growth-compromised, functionally abnormal, or potentially malignant cells from tissues through selective removal (<xref ref-type="bibr" rid="B39">van Neerven and Vermeulen, 2022</xref>), thereby maintaining organismal health and homeostasis. This phenomenon was first described in studies of <italic>Drosophila</italic>, where cells from flies carrying a heterozygous mutation in the Minute gene (<italic>Minute</italic>&#x2b;/&#x2212;) survived and proliferated normally in isolation, exhibiting only mild phenotypic alterations such as reduced body size. However, they were recognized and selectively eliminated by apoptosis when placed adjacent to wild-type cells (<xref ref-type="bibr" rid="B13">Gines and Ripoll, 1975</xref>). This contact-dependent clearance provided the first evidence that cell competition acts as an adaptive mechanism for removing less-fit cells. Subsequent studies have demonstrated that not only genetically defective cells but also those with reduced proliferation rates, impaired damage-repair capacity, or metabolic disturbances can be eliminated by surrounding fitter cells via this process (<xref ref-type="bibr" rid="B31">Plusa et al., 2008</xref>). These findings offer an important theoretical basis for understanding the obstacles to interspecies cell coexistence.</p>
<p>Mesenchymal stem cells (MSCs) are a class of adult stem cells characterized by their self-renewal capacity, multipotent differentiation potential, and immunomodulatory functions, which hold significant value in the field of regenerative medicine (<xref ref-type="bibr" rid="B14">Han et al., 2019</xref>). As pivotal regulators of the tissue microenvironment, MSCs are widely distributed in the stroma of bone marrow, adipose tissue, and connective tissue. Elucidating the mechanisms by which MSCs exert their effects in cellular competition can reveal their crucial roles in various physiological and pathological processes, including tissue regeneration, stem cell transplantation and organismal aging (<xref ref-type="bibr" rid="B26">Marques-Reis and Moreno, 2021</xref>; <xref ref-type="bibr" rid="B30">Nowlan et al., 2021</xref>; <xref ref-type="bibr" rid="B17">Huang et al., 2023</xref>; <xref ref-type="bibr" rid="B5">Barcelona-Estaje et al., 2024</xref>; <xref ref-type="bibr" rid="B20">Khandekar and Ellis, 2024</xref>). Compared to pluripotent stem cells (PSCs), bone marrow-derived MSCs more closely approximate <italic>in vivo</italic> physiological conditions and possess distinct advantages, including low immunogenicity, reduced tumorigenic potential, and fewer ethical concerns (<xref ref-type="bibr" rid="B1">Adelipour et al., 2023</xref>). These features make MSCs an ideal model for both <italic>in vitro</italic> experimentation and <italic>in vivo</italic> transplantation studies.</p>
<p>Notably, human MSCs (hMSCs) and porcine MSCs (pMSCs) exhibit high similarity in core biological characteristics and functionalities. In terms of cell morphology, both cell types adhere to substrates and display a typical spindle shape, with hMSCs presenting a more elongated form compared to pMSCs. Regarding surface marker expression, both cell types demonstrate cross-species conservation. In terms of proliferation capacity, there are no significant differences between hMSCs and pMSCs in their <italic>in vitro</italic> growth potential (<xref ref-type="bibr" rid="B29">Noort et al., 2012</xref>). Concerning differentiation potential, both cell types possess stable tri-lineage differentiation capabilities towards osteogenic, adipogenic, and chondrogenic lineages. Immunologically, both hMSCs and pMSCs exhibit low immunogenicity and significant immunomodulatory activity, effectively suppressing phytohemagglutinin-induced T-cell proliferation (<xref ref-type="bibr" rid="B8">Comite et al., 2011</xref>). Based on these characteristics, this study selected hMSCs and pMSCs as research models to systematically describe the competitive interactions between them and elucidate the underlying molecular mechanisms governing this process. Ultimately, our work aims to provide new experimental foundations for improving human cell survival in porcine hosts and advancing the study of xenotransplantation.</p>
</sec>
<sec sec-type="results" id="s2">
<label>2</label>
<title>Results</title>
<sec id="s2-1">
<label>2.1</label>
<title>Isolation and characterization of pMSCs</title>
<p>pMSCs were isolated from the bone marrow of femurs and tibiae obtained under aseptic conditions from healthy piglets. Initially, primary (P0) pMSCs appeared scattered after adhesion. After 72&#xa0;h, pMSCs proliferated to form distinct colony clusters. Upon passaging, the cells adopted a homogeneous, elongated, spindle-shaped morphology (<xref ref-type="fig" rid="F1">Figures 1A,B</xref>). The isolated cells were positive for the mesenchymal stem cell markers CD90 and CD44 (both &#x3e;98% positivity) and negative for the hematopoietic and immune markers CD4, CD14, CD19, CD34, CD45 and CD80, confirming a characteristic pMSC surface phenotype (<xref ref-type="fig" rid="F1">Figure 1C</xref>; <xref ref-type="sec" rid="s13">Supplementary Figures S1A&#x2013;C</xref>). The multipotent differentiation potential was evaluated by inducing osteogenic, adipogenic, and chondrogenic lineages. After induction, the formation of calcium nodules was confirmed by Alizarin Red staining, lipid droplet accumulation was revealed by Oil Red O staining, and glycosaminoglycan deposition in the cartilage matrix was detected by Alcian Blue staining (<xref ref-type="fig" rid="F1">Figure 1D</xref>). These results verify that pMSCs have the capability to differentiate into osteocytes, adipocytes, and chondrocytes. In summary, through morphological assessment, surface marker analysis, and multilineage differentiation assays, we successfully isolated and expanded highly pure and functional pMSCs.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Extraction and characterization of pMSCs. <bold>(A)</bold> Schematic diagram of the pMSCs extraction process by Figdraw. <bold>(B)</bold> Representative images of the primary pMSCs. <bold>(C)</bold> Flow cytometric analysis of surface marker on pMSCs. <bold>(D)</bold> Identification of the multi-lineage differentiation potential of pMSCs. </p>
</caption>
<graphic xlink:href="fcell-14-1750289-g001.tif">
<alt-text content-type="machine-generated">Panel A shows a schematic diagram illustrating the isolation of bone marrow-derived cells from a pig bone marrow of femurs and tibiae. Panel B displays microscope images comparing primary (P0) and passage three (P3) adherent cells, with scale bars of 800 micrometers and 400 micrometers, respectively. Panel C presents Flow cytometric analysis of surface marker on pMSCs, including CD44, CD90, CD14, CD45, and CD34. Panel D contains multi-lineage differentiation potential of pMSCs.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-2">
<label>2.2</label>
<title>pMSCs inhibit hMSCs proliferation by inducing apoptosis in the direct co-culture system</title>
<p>The efficacy of human cell xenotransplantation into porcine hosts may be limited by interspecies physiological differences, particularly with respect to body temperature and the competition among xenogeneic cells. We first investigated the impact of temperature using CCK-8 assays. The results indicated that the physiological temperature of pigs (39&#xa0;&#xb0;C) significantly inhibited the proliferation of hMSCs. In contrast, the proliferation of pMSCs was not significantly affected when comparing 37&#xa0;&#xb0;C&#x2013;39&#xa0;&#xb0;C, underscoring their strong adaptability to human body temperature. These findings demonstrate that the porcine thermal environment exerts a substantial inhibitory effect on hMSCs (<xref ref-type="fig" rid="F2">Figures 2A,B</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Direct co-culture of human and porcine MSCs. <bold>(A)</bold> The proliferation of hMSCs cultured at 37&#xa0;&#xb0;C and 39&#xa0;&#xb0;C. <bold>(B)</bold> The proliferation of pMSCs cultured at 37&#xa0;&#xb0;C and 39&#xa0;&#xb0;C. <bold>(C)</bold> Schematic diagram illustrating the direct co-culture system of human and porcine MSCs by Figdraw. <bold>(D)</bold> The percentage of GFP-labeled hMSCs under direct co-culture conditions at 37&#xa0;&#xb0;C and 39&#xa0;&#xb0;C (pMSCs: hMSCs &#x3d; 1: 1). <bold>(E)</bold> The proliferation curve of hMSCs under direct co-culture conditions at 37&#xa0;&#xb0;C and 39&#xa0;&#xb0;C (pMSCs: hMSCs &#x3d; 1: 1). Data are represented as mean &#xb1; standard error. &#x2a;, <italic>P</italic> &#x3c; 0.05; &#x2a;&#x2a;, <italic>P</italic> &#x3c; 0.01.</p>
</caption>
<graphic xlink:href="fcell-14-1750289-g002.tif">
<alt-text content-type="machine-generated">Panel A shows a line graph comparing relative CCK8 OD450 values for hMSC-L and hMSC-H over 5 days, with hMSC-H increasing significantly by day 5. Panel B presents a similar graph for pMSC-L and pMSC-H, both rising comparably. Panel C contains an illustration of experimental setups for separate and co-culture conditions of human and porcine MSC at 37 and 39 degrees Celsius. Panel D displays flow cytometry dot plots for MSC-L and MSC-H at days 0, 4, and 8, showing a decrease in FITC-positive counts over time. Panel E depicts a line graph of relative cell number fold changes for L and H in separate and co-culture conditions, with L separate culture showing the highest increase by day 8.</alt-text>
</graphic>
</fig>
<p>We then investigated the interactions between human and porcine cells by four experiments: hMSCs were cultured at 37&#xa0;&#xb0;C (L separate culture), hMSCs were cultured at 39&#xa0;&#xb0;C (H separate culture), hMSCs were co-cultured with pMSCs at 37&#xa0;&#xb0;C (L co-culture), and hMSCs were co-cultured with pMSCs at 39&#xa0;&#xb0;C (H co-culture). The proliferation of GFP-labeled hMSCs was evaluated using cell counting and flow cytometry (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Flow cytometric analysis revealed a time-dependent decline in the proportion of GFP-positive hMSCs during co-culture. Compared to the separate culture group, the proliferation rate of hMSCs was significantly reduced under co-culture conditions (<xref ref-type="fig" rid="F2">Figures 2D,E</xref>). These results indicate that pMSCs could impair the survival and proliferation of hMSCs under co-culture conditions at both 37&#xa0;&#xb0;C and 39&#xa0;&#xb0;C, thereby influencing the overall efficiency of human cell xenotransplantation.</p>
<p>Given that porcine cells significantly outnumber human cells during xenotransplantation of human cells into pigs, we examined the effect of pMSC concentration on hMSC proliferation through five experimental groups: hMSCs cultured alone and hMSCs co-cultured with pMSCs at cell number ratios of 1:1, 1:4, 1:6, and 1:9. The results indicated that higher pMSC ratios led to a stronger inhibition of hMSC proliferation, which was consistently observed at both 37&#xa0;&#xb0;C and 39&#xa0;&#xb0;C (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>). Notably, the higher temperature (39&#xa0;&#xb0;C) and co-culture exerted a synergistic inhibitory effect on hMSC proliferation. To investigate the underlying mechanism, immunofluorescence analysis was performed, and the results revealed a markedly increased expression of the apoptosis-related protein cleaved caspase-3 in GFP-labeled hMSCs under co-culture conditions compared to the control (<xref ref-type="fig" rid="F3">Figures 3C,D</xref>), suggesting that pMSCs may inhibit proliferation by inducing apoptosis in hMSCs through undefined mechanisms.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>The effect of different proportions of pMSCs on the proliferation of hMSCs. <bold>(A)</bold> The effects of different inoculation ratios of pMSCs on the proliferation of hMSCs at 37&#xa0;&#xb0;C. <bold>(B)</bold> The effects of different inoculation ratios of pMSCs on the proliferation of hMSCs at 39&#xa0;&#xb0;C. <bold>(C)</bold> The expression of c-caspase3 protein in hMSCs within the direct co-culture system. <bold>(D)</bold> Statistical analysis of the mean fluorescence intensity of c-caspase3 protein. Data are represented as mean &#xb1; standard error. &#x2a;, <italic>P</italic> &#x3c; 0.05; &#x2a;&#x2a;, <italic>P</italic> &#x3c; 0.01.</p>
</caption>
<graphic xlink:href="fcell-14-1750289-g003.tif">
<alt-text content-type="machine-generated">Panel A shows a line graph comparing relative cell numbers over time for different L cell culture conditions, with separate culture growing more than co-culture conditions. Panel B presents a similar line graph for H cell culture conditions, showing the same trend. Panel C contains fluorescence microscopy images comparing c-caspase3 (red), GFP (green), and DAPI-stained nuclei (blue) in separate versus co-culture, with merged images included; each image is labeled with a 30 micrometer scale bar. Panel D displays a violin plot comparing mean c-caspase3 signal intensity between separate and co-culture, with higher intensity in co-culture and a significant difference indicated by double asterisks.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-3">
<label>2.3</label>
<title>The soluble factors secreted by pMSCs are not the primary agents inhibiting hMSC proliferation</title>
<p>To elucidate the potential mechanisms underlying the inhibition of hMSC proliferation mediated by pMSCs, we employed a transwell non-contact co-culture assay to investigate whether the soluble factors secreted by pMSCs contribute to the suppression of hMSC growth. Notably, the results demonstrated that pMSCs at different proportions in the non-contact co-culture system did not significantly affect hMSC proliferation (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>), suggesting that the inhibitory effect of pMSCs on hMSCs may be attributed to the direct cell-to-cell contact rather than to the secreted soluble factors.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Indirect co-culture of human and porcine MSCs. <bold>(A)</bold> Schematic diagram of the transwell-based indirect co-culture system for human and porcine MSCs. <bold>(B)</bold> The proliferation of hMSCs under transwell indirect co-culture conditions. <bold>(C)</bold> Schematic diagram of the extraction process for conditioned medium. <bold>(D)</bold> The effect of pMSC-derived conditioned medium on hMSC proliferation.</p>
</caption>
<graphic xlink:href="fcell-14-1750289-g004.tif">
<alt-text content-type="machine-generated">Diagram with four panels related to mesenchymal stem cell indirect co-culture. Panel A: Schematic diagram of the transwell-based indirect co-culture system for human and porcine MSCs . Panel B: bar graph showing relative CCK8 OD450 values for different cell ratios in separate versus co-culture. Panel C: stepwise schematic for preparing clarified conditioned media, detailing centrifugation and filtration steps. Panel D: line graph depicting increases in relative CCK8 OD450 over 36 hours for different concentrations of MSC-CM.</alt-text>
</graphic>
</fig>
<p>To further validate the role of soluble factors, the conditioned medium (CM) from pMSCs was extracted and purified. The impact of the CM on hMSC proliferation was assessed via CCK-8 assays at varying concentrations and treatment times. The results indicated that concentrations of 200&#x2013;400 &#x03BC;g/ml of pMSC-CM did not exert a significant effect on hMSC proliferation. Treatment with 600&#xa0;&#x3bc;g/mL of CM for 12&#xa0;h induced a slight promotion, which disappeared when the treatment time was extended to 24&#xa0;h (<xref ref-type="fig" rid="F4">Figures 4C,D</xref>). The modest promotion observed at the 12-h time point for pMSC-CM may attribute to the presence of growth factors, cytokines, and other bioactive components. However, many of these factors have relatively shorter half-lives, complicating the maintenance of their activity over extended periods. Furthermore, subtle variations in the concentrations of active components may occur between different batches of pMSC-CM, contributing to the observed fluctuations in the promotional effect at the 12-h time point across multiple independent replicate experiments. These results suggest that the soluble factors secreted by pMSCs may not be the primary inhibitors of hMSC proliferation.</p>
</sec>
<sec id="s2-4">
<label>2.4</label>
<title>pMSCs suppress hMSC proliferation by activating the NF-&#x3ba;B pathway</title>
<p>To elucidate the molecular mechanisms underlying the suppression of hMSC proliferation by pMSCs, we isolated GFP-labelled hMSCs from the co-culture system using cell sorting technology and conducted RNA-seq analysis (<xref ref-type="fig" rid="F5">Figure 5A</xref>). Compared to monoculture, hMSCs in co-culture exhibited significant upregulation of 889 genes and downregulation of 270 genes. Notably, several proliferation-related genes, including <italic>CYP1B1</italic>, <italic>SLC7A11</italic>, <italic>PSAT1</italic>, and <italic>TFAP2C</italic>, were significantly downregulated in the co-culture group, which was further confirmed by qPCR (<xref ref-type="fig" rid="F5">Figures 5B,C</xref>). Gene Ontology (GO) enrichment analysis indicated that the differentially expressed genes were primarily associated with biological processes such as endoplasmic reticulum protein folding, response to misfolded proteins, and amino acid transport, suggesting that co-culture disrupts protein homeostasis and metabolic functions in hMSCs (<xref ref-type="fig" rid="F5">Figure 5D</xref>). Given that direct cell-cell contact could cause an inhibitory effect on proliferation, we next examined the expression alterations of cell junction-related molecules. Notably, significant downregulation of key tight junction molecules, including <italic>OCLN</italic>, <italic>CLDN1</italic>, <italic>CLDN11</italic>, and <italic>TJP1</italic>, was found in co-cultured hMSCs. Among adhesion junction-associated molecules, the baseline expression level of <italic>CDH1</italic> (encoding &#x3b1;-catenin) decreased, whereas <italic>CDH2</italic> (encoding &#x3b2;-catenin) showed no significant difference between groups we tested (<xref ref-type="fig" rid="F5">Figure 5E</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>RNA sequencing of hMSCs under direct co-culture conditions. <bold>(A)</bold> Schematic diagram by Figdraw illustrating the experimental procedure that GFP-labeled hMSCs were sorted by flow cytometry from direct co-culture systems, followed by RNA-seq analysis. <bold>(B)</bold> Volcano plot of DEGs in hMSCs. <bold>(C)</bold> qPCR analysis for CYP1B1, SLC7A11, PSAT1 and TFAP2C. <bold>(D)</bold> GO functional enrichment analysis results for DEGs in hMSCs. <bold>(E)</bold> qPCR analysis for OCLN, CLDN1, CLDN11, TJP1 and CDH2. Data are represented as mean &#xb1; standard error. &#x2a;, <italic>P</italic> &#x3c; 0.05; &#x2a;&#x2a;, <italic>P</italic> &#x3c; 0.01.</p>
</caption>
<graphic xlink:href="fcell-14-1750289-g005.tif">
<alt-text content-type="machine-generated">Panel A displays an experimental workflow diagram for culturing and sorting human and porcine mesenchymal stem cells (MSCs) before RNA sequencing. Panel B presents a volcano plot of differential gene expression, highlighting significant upregulated and downregulated genes. Panel C shows a bar graph comparing relative mRNA expression levels of four genes between separate culture and co-culture conditions. Panel D is a horizontal bar chart of gene ontology terms with counts, colored by p-value significance. Panel E provides a bar graph comparing expression levels of five genes relevant to cell junctions between the two culture conditions.</alt-text>
</graphic>
</fig>
<p>Moreover, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed significant enrichment of signaling pathways associated with cellular competition and proliferation regulation, including NF-&#x3ba;B, PI3K-AKT, and JAK-STAT. Among these, alterations in the NF-&#x3ba;B pathway were particularly pronounced (<xref ref-type="fig" rid="F6">Figure 6A</xref>; <xref ref-type="sec" rid="s13">Supplementary Figures 2A-C</xref>). qPCR results confirmed that the mRNA expression of key NF-&#x3ba;B pathway genes, <italic>IL1B</italic> and <italic>TNFAIP3</italic>, was significantly upregulated in co-cultured hMSCs (<xref ref-type="fig" rid="F6">Figure 6B</xref>). Employing <italic>in vitro</italic> stimulation of hMSCs with interleukin-1&#x3b2; (IL-1&#x3b2;), the activation status of the NF-&#x3ba;B pathway and its role in regulating hMSC proliferation was further investigated. Western blot (WB) analysis demonstrated a decrease in I&#x3ba;B&#x3b1; expression alongside elevated levels of p-I&#x3ba;B&#x3b1; and TNF&#x3b1;, confirming NF-&#x3ba;B pathway activation. Importantly, following NF-&#x3ba;B activation, the expression levels of cyclin D1 and proliferating cell nuclear antigen (PCNA) proteins were significantly downregulated, suggesting an impairment in cellular proliferation capacity (<xref ref-type="fig" rid="F6">Figure 6C</xref>). Further immunofluorescence results indicated a significant reduction in the mean fluorescence intensity of the proliferation marker protein Ki67 in the IL-1&#x3b2;-treated group (<xref ref-type="fig" rid="F6">Figures 6D,E</xref>). Moreover, the CCK-8 assay confirmed that the cell proliferation was markedly suppressed following IL-1&#x3b2; treatment (<xref ref-type="fig" rid="F6">Figure 6F</xref>). These findings collectively suggest that pMSCs impair the proliferative capacity of hMSCs by activating the NF-&#x3ba;B pathway.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>pMSCs suppress hMSC proliferation by activating the NF-&#x3ba;B pathway. <bold>(A)</bold> KEGG pathway enrichment analysis results for DEGs in hMSCs. <bold>(B)</bold> qPCR analysis for IL1B and TNFAIP3. <bold>(C)</bold> Western blot analysis of NF-&#x3ba;B pathway-related proteins IKB&#x3b1;, p-IKB&#x3b1;, TNF&#x3b1;, cyclinD1 and PCNA in hMSCs treated by 10, 20, or 40&#xa0;ng/mL of IL-1&#x3b2;. <bold>(D)</bold> Immunofluorescence staining of Ki67 protein after IL-1&#x3b2; treatment. <bold>(E)</bold> Statistical analysis of the mean fluorescence intensity of Ki67 protein. <bold>(F)</bold> CCK-8 assay showing the proliferation of hMSCs after IL-1&#x03B2; treatment Data are represented as mean &#xb1; standard error. &#x2a;, <italic>P</italic> &#x3c; 0.05; &#x2a;&#x2a;, <italic>P</italic> &#x3c; 0.01.</p>
</caption>
<graphic xlink:href="fcell-14-1750289-g006.tif">
<alt-text content-type="machine-generated">Panel A shows KEGG pathway enrichment analysis results for DEGs in hMSCs. Panel B presents a bar chart comparing relative mRNA expression of IL1B and TNFAIP3 between separate and co-culture conditions, showing higher expression in co-culture with statistical significance. Panel C displays Western blot images for IL-1&#x3B2; treatment at increasing concentrations, probing for I&#x3BA;B&#x3B1;, phosphorylated I&#x3BA;B&#x3B1;, TNF&#x3B1;, PCNA, cyclin D1, and vinculin. Panel D provides fluorescence microscopy images with Ki67 (green), DAPI (blue), and merged channels, comparing control and IL-1&#x3B2; treated cells; fewer green Ki67-positive cells are seen in treated samples. Panel E is a violin plot showing reduced mean Ki67 signal intensity in IL-1&#x3B2; treated cells compared to control. Panel F contains a CCK-8 assay showing the proliferation of hMSCs after IL-1&#x03B2; treatment, with a dose-dependent decrease and significant differences noted.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s3">
<label>3</label>
<title>Discussion</title>
<p>Cell competition was first described in <italic>Drosophila</italic> and has been recognized as a widespread phenomenon involved in embryonic development, organ maturation, xenotransplantation, tissue homeostasis, and disease progression. During embryonic development, cell competition serves as an important quality control mechanism to maintain developmental homeostasis by selectively eliminating abnormal cells. In the process of inner cell mass formation, competition driven by differential FGF4 signaling promotes the distinct differentiation of NANOG<sup>&#x2b;</sup> epiblast and GATA6<sup>&#x2b;</sup> hypoblast cells (<xref ref-type="bibr" rid="B7">Chazaud and Yamanaka, 2016</xref>). Studies show that transplanting cells with <italic>Robo4</italic> mutations into bone marrow significantly impairs their niche competitiveness, accompanied by a compensatory increase in <italic>Cxcr4</italic> expression. This suggests that modulating <italic>Robo4</italic> may represent a potential strategy to enhance the competitiveness of hematopoietic stem cells in transplantation settings (<xref ref-type="bibr" rid="B37">Smith-Berdan et al., 2011</xref>).</p>
<p>A hallmark of cell competition is the selective elimination of less-fit cells, which often display metabolic and functional impairments, such as aberrant protein synthesis, perturbations in glycolysis, and mitochondrial dysfunction. Studies have shown that RasV12-transformed MDCK cells are eliminated through apical extrusion, a process accompanied by obvious metabolic reprogramming characterized by increased glucose uptake, elevated lactate dehydrogenase expression, heightened lactate secretion, and a complete loss of mitochondrial activity. Importantly, the inhibition of pyruvate dehydrogenase kinase four activity can rescue these cells from extrusion (<xref ref-type="bibr" rid="B21">Kon et al., 2017</xref>). Metabolic differences between adjacent cells are key factors determining competitive fitness. For example, cells with elevated <italic>Myc</italic> expression undergo a glycolytic shift, significantly enhancing their competitive ability and proliferative capacity via a p53 dependent pathway (<xref ref-type="bibr" rid="B10">de la Cova et al., 2014</xref>). In mice carrying a mutation in the ribosomal protein Rpl24, mutant cells are gradually lost during chimera formation with wild-type cells, indicating that ribosomal dysfunction confers a competitive disadvantage (<xref ref-type="bibr" rid="B11">Edward R et al., 2004</xref>).</p>
<p>Signaling pathways such as NF-&#x3ba;B, PI3K-AKT, JAK-STAT, Hippo, Notch, and mTOR play crucial roles in regulating the outcomes of cellular competition. Specifically, the NF-&#x3ba;B and JAK-STAT pathways mediate the elimination of disadvantaged cells. In <italic>Myc</italic>-overexpression-induced cell competition, mutations in the NF-&#x3ba;B homolog Rel or its key regulator Dredd impede the apoptotic clearance of these disadvantaged cells (<xref ref-type="bibr" rid="B27">Meyer et al., 2014</xref>). Furthermore, cells exhibiting elevated STAT activity can eliminate disadvantaged cells through hid-dependent mechanisms (<xref ref-type="bibr" rid="B33">Rodrigues et al., 2012</xref>). The PI3K-AKT pathway positively regulates cell survival and competitive advantage, and its synergistic activation with <italic>Myc</italic> overexpression significantly enhances the acquisition of winner status (<xref ref-type="bibr" rid="B34">Sander et al., 2012</xref>). Notch signaling demonstrates environment-dependent regulation in mammalian systems. In the esophageal epithelium, Notch-inhibited cells achieve clonal proliferation, potentially by promoting the differentiation and clearance of surrounding wild-type cells (<xref ref-type="bibr" rid="B4">Alcolea et al., 2014</xref>). Inhibition of the Hippo and mTOR pathways typically renders cells susceptible to elimination. During embryonic ectoderm formation, cells with reduced expression of TEAD/YAP, downstream effectors of the Hippo pathway, are eliminated via apoptosis (<xref ref-type="bibr" rid="B15">Hashimoto and Sasaki, 2019</xref>). Similarly, cells with suppressed mTOR signaling are eliminated when coexisting with wild-type cells, whereas abnormal activation of mTOR signaling under stress may induce apoptosis through Bax-mediated pathways (<xref ref-type="bibr" rid="B18">Javedan et al., 2016</xref>; <xref ref-type="bibr" rid="B6">Bowling et al., 2018</xref>).</p>
<p>Overcoming interspecies cellular competition barriers is a fundamental challenge in enhancing the efficiency of xenotransplantation of human-derived cells. In interspecies co-culture systems, competitive interactions between host cells and transplanted cells frequently suppress the survival and proliferation of human cells, significantly constraining chimerism efficiency. Wang et al. found that activation of the NF-&#x3ba;B signaling pathway in human PSCs led to their competitive elimination in a human-mouse PSCs co-culture system. Consistently, inhibiting p65 or MYD88 in human cells effectively counteracted this competition, substantially improving human cell survival and chimerism in mouse early embryos (<xref ref-type="bibr" rid="B44">Zheng et al., 2021</xref>). Subsequent research by the same team revealed interspecies RNA exchange within human-mouse PSCs co-culture systems, activating the RNA innate immune pathway in mouse&#xa0;cells and mediating the competitive clearance of human cells. Knocking out key proteins RIG-I or MAVS in this pathway significantly weakened the competitive advantage of mouse&#xa0;cells, thereby substantially improving human cell survival rates and embryonic chimerism rates without modifying human cells (<xref ref-type="bibr" rid="B16">Hu et al., 2025</xref>).</p>
<p>The low survival rate of human-derived cells in pigs remains a significant bottleneck that restricts the clinical application of xenotransplantation. However, the impact of porcine cells on human cell growth has rarely been investigated. Given the absence of established porcine PSCs with high chimeric capability, this study developed an <italic>in vitro</italic> direct co-culture model of hMSCs and pMSCs to investigate the effect of interspecies cellular competition. Our results demonstrated that, compared to hMSCs cultured alone, the proliferation of hMSCs in the co-culture system was significantly suppressed. Further adjustments to the seeding ratios revealed that as the proportion of pMSCs increased, the inhibitory effect on hMSC proliferation correspondingly intensified. Furthermore, transwell indirect co-culture and CM treatment experiments confirmed that the inhibition of hMSC proliferation by pMSCs is independent of paracrine factors but closely associated with direct cell-cell contact. To further investigate the underlying molecular mechanisms, we performed RNA sequencing analysis and found that direct hMSC&#x2013;pMSC contact significantly downregulated the expression of several proliferation-related genes in hMSCs, including <italic>CYP1B1</italic>, <italic>SLC7A11</italic>, <italic>TFAP2C</italic>, and <italic>PSAT1</italic> (<xref ref-type="bibr" rid="B19">Kang et al., 2016</xref>; <xref ref-type="bibr" rid="B3">Al-Dhfyan et al., 2017</xref>; <xref ref-type="bibr" rid="B12">Fantone et al., 2024</xref>; <xref ref-type="bibr" rid="B23">Liu et al., 2025</xref>). Previous studies have demonstrated that tight junctions and adherens junctions significantly influence the outcomes of cellular competition (<xref ref-type="bibr" rid="B36">Skamrahl et al., 2021</xref>). Our analysis on the expression patterns of genes related to cell junctions revealed that the mRNA levels of key tight junction molecules, <italic>OCLN</italic>, <italic>CLDN1</italic>, <italic>CLDN11</italic>, and <italic>TJP1</italic>, were significantly downregulated in the co-culture system, whereas the expression of <italic>CDH2</italic> in adherens junctions remained unchanged. This suggests that cell contact exerts its effects by influencing the structure or function of tight junctions.</p>
<p>In the present study, GO enrichment analysis revealed that differentially expressed genes were primarily associated with endoplasmic reticulum protein folding, responses to misfolded proteins, and amino acid transport. This suggests that interspecies cell competition between human and porcine cells may disrupt protein processing homeostasis and metabolic functions in hMSCs, thereby affecting their survival and proliferative capacity. KEGG pathway enrichment analysis revealed significant activation of pathways closely linked to cellular competition and proliferation regulation, including NF-&#x3ba;B, PI3K-AKT, and JAK-STAT, in co-cultured hMSCs, with the enrichment of the NF-&#x3ba;B pathway being the most pronounced. Excessive activation of the NF-&#x3ba;B pathway may represent a key mechanism underlying the competitive disadvantage of hMSCs in co-culture conditions. Consequently, modulating the activity of this pathway holds promise for mitigating the competitive disadvantage of hMSCs, thereby enhancing their survival rates within complex microenvironments such as allogeneic transplantation.</p>
</sec>
<sec sec-type="conclusion" id="s4">
<label>4</label>
<title>Conclusion</title>
<p>In a direct co-culture system involving human and porcine MSCs, the presence of pMSCs inhibits the proliferation of hMSCs. RNA sequencing results indicate that direct co-culture significantly downregulates the expression of proliferation-related genes in hMSCs, disrupting endoplasmic reticulum function and amino acid transport processes. Further investigations revealed that pMSCs impair the proliferative capacity of hMSCs partially by activating the NF-&#x3ba;B pathway in the latter.</p>
</sec>
<sec sec-type="materials|methods" id="s5">
<label>5</label>
<title>Materials and methods</title>
<sec id="s5-1">
<label>5.1</label>
<title>Cell culture</title>
<p>Human fetal bone marrow MSCs were purchased from Cyagen Biosciences (HUXMF-01001, China). hMSCs and pMSCs were cultured in low-glucose Dulbecco&#x2019;s Modified Eagle&#x2019;s Medium (DMEM) (Gibco, USA) supplemented with 10% fetal bovine serum (OriCell, China), 1% non-essential amino acids (Gibco, USA), 1% GlutaMAX (Gibco, USA), and 1% penicillin-streptomycin (Transgen, China) at 95% humidity and 5% CO<sub>2</sub>, with temperatures set at either 37&#xa0;&#xb0;C or 39&#xa0;&#xb0;C. HEK293FT cells were maintained in DMEM (Gibco, USA) supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin.</p>
</sec>
<sec id="s5-2">
<label>5.2</label>
<title>Extraction of pMSCs</title>
<p>Healthy piglets within 7 days postnatally were selected. Under aseptic conditions, the femurs and tibiae were dissected, disinfected twice with 75% ethanol, and rinsed three times with phosphate-buffered saline (PBS) containing penicillin-streptomycin. Bone marrow was flushed out using complete medium and cultured at 37&#xa0;&#xb0;C with 5% CO<sub>2</sub> under 95% humidity. Half of the medium was replaced every 12&#xa0;h. After 72&#xa0;h, the culture dish was washed twice with PBS to remove non-adherent cells, and complete medium was replenished for continued culture. Thereafter, the medium was changed every 3 days. Upon reaching 80%&#x2013;90% confluence, the cells were either cryopreserved or passaged for subsequent experiments.</p>
</sec>
<sec id="s5-3">
<label>5.3</label>
<title>Expression of pMSCs surface markers</title>
<p>pMSCs (1 &#xd7; 10<sup>6</sup>) were washed with FACS buffer and resuspended in 100&#xa0;&#x3bc;L of FACS buffer. The cells were incubated at 4&#xa0;&#xb0;C for 30&#xa0;min in the dark with fluorochrome-conjugated primary antibodies: anti-CD90 APC (559869, BD), anti-CD44 BV785 (103041, BD), anti-CD45 BV480 (566115, BD), anti-CD14 BV650 (563420, BD), and anti-CD34 FITC (555821, BD). After washing, the cells were analyzed using A5 flow cytometry, and the data were processed using FlowJo software.</p>
</sec>
<sec id="s5-4">
<label>5.4</label>
<title>Osteogenic differentiation</title>
<p>pMSCs were seeded into a 12-well plate at a density of 2 &#xd7; 10<sup>4</sup> cells per well. Once the cell density reached 70%, the medium was replaced with osteogenic induction medium (OriCell, China), which was changed every 3&#xa0;days during the osteogenic differentiation process. On day 9, when calcium nodule formation was observed, the cells were fixed with 4% paraformaldehyde (PFA) for 30&#xa0;min. Subsequently, the cells were stained with alizarin red for 5&#x2013;10&#xa0;min. The results were then observed and photographed under microscope.</p>
</sec>
<sec id="s5-5">
<label>5.5</label>
<title>Lipidogenic differentiation</title>
<p>Cells were seeded into a 12-well plate at a density of 3 &#xd7; 10<sup>4</sup> cells per well. Once the cell density reached 100%, the medium was replaced with adipogenic induction medium A (OriCell, China). After 3&#xa0;days of culture, medium A was substituted with induction medium B, and the two media were alternated thereafter. Approximately 2&#xa0;weeks later, when lipid droplet formation was observed, the cells were fixed with 4% PFA for 30&#xa0;min. Subsequently, the cells were stained with Oil Red O for 30&#xa0;min. The results were then observed and photographed under a microscope.</p>
</sec>
<sec id="s5-6">
<label>5.6</label>
<title>Chondrogenic differentiation</title>
<p>pMSCs were cultured at a density of 4 &#xd7; 10<sup>5</sup> cells in 15&#xa0;mL tubes and centrifuged at 250&#xa0;<italic>g</italic> for 5&#xa0;min. The cell pellets were resuspended in 0.5&#xa0;mL of chondrogenic media (OriCell, China) and subjected to a second centrifugation at 150&#xa0;<italic>g</italic> for 5&#xa0;min. The chondrogenic media was replaced every 2&#xa0;days until chondrospheres were observed. Subsequently, the chondrospheres were fixed in 4% PFA for 30&#xa0;min. Following fixation, the chondrospheres were embedded in optimal cutting temperature compound and stored at &#x2212;80&#xa0;&#xb0;C. Continuous frozen sections were prepared, and Alcian blue staining was performed. The results were then observed and photographed under a microscope.</p>
</sec>
<sec id="s5-7">
<label>5.7</label>
<title>Cell proliferation assays</title>
<p>Cell proliferation assays were conducted using a CCK-8 reagent (Beyotime, China). Cells were seeded in 96-well plates at a density of 1 &#xd7; 10<sup>3</sup> cells per well in 100&#xa0;&#x3bc;L of complete medium. At the indicated time points, 10&#xa0;&#x3bc;L of CCK-8 reagent was added to each well and incubated at 37&#xa0;&#xb0;C for 2&#xa0;h. The absorbance was measured at 450&#xa0;nm. All samples were tested in three independent experiments.</p>
</sec>
<sec id="s5-8">
<label>5.8</label>
<title>Generation of GFP-hMSCs</title>
<p>The pLenti-CMV-GFP cloning vector (Addgene 17448), psPAX2, and pMD2.G were co-transfected into HEK293FT cells using Lipofectamine 2000 reagent (Invitrogen, USA) according to the manufacturer&#x2019;s instructions. The culture supernatant containing lentivirus was collected and concentrated using ultrafiltration centrifuge tubes (Millipore, USA). MSCs were seeded in a 12-well plate at a density of 3 &#xd7; 10<sup>4</sup> cells per well and cultured until reaching 30%&#x2013;40% confluence. The cells were infected with the concentrated lentivirus and 5&#xa0;&#x3bc;g/mL Polybrene (Sigma, USA) to enhance transduction efficiency. After 12&#xa0;h of infection, the virus-containing medium was removed, and fresh complete medium was added for continued cultivation. About 7 days later, GFP-positive cells were sorted using a BD flow cytometer (BD, USA) after digestion with 0.25% trypsin and filtration through a 70&#xa0;&#x3bc;m sterile cell strainer. The sorted cells were cultured for 1&#xa0;week to establish stable cell lines. The transduction efficiency of the lentivirus was confirmed through qPCR and WB analysis.</p>
</sec>
<sec id="s5-9">
<label>5.9</label>
<title>Direct co-culture of human and porcine MSCs</title>
<p>The experiment included five groups: hMSCs cultured alone, and hMSCs co-cultured with pMSCs at ratios of 1:1, 1:4, 1:6, and 1:9. The initial total cell number was kept postnatally across all groups by adjusting the seeding density of each cell type. On days 4 and 8 after seeding, the cells were digested and collected. The total cell number was obtained using a cell counter, and the proportion of GFP-positive hMSCs was determined by flow cytometry. The absolute number of hMSCs in each group was calculated by multiplying the total cell count by the percentage of GFP-positive cells. Data were processed using the formula: normalized growth curve &#x3d; log<sub>e</sub>(final cell number/initial cell number)/log<sub>e</sub>2, and the normalized growth curve of hMSCs was plotted accordingly.</p>
</sec>
<sec id="s5-10">
<label>5.10</label>
<title>Immunofluorescence staining (IF)</title>
<p>The indicated cells (1 &#xd7; 10<sup>4</sup>) were seeded on glass slides in 24-well plates. The cells were washed with PBS and fixed in 4% PFA for 20&#xa0;min at room temperature. Fixed cells were permeabilized with 1% Triton X-100 for 10&#xa0;min and blocked with 1% bovine serum albumin supplemented with 22.52&#xa0;mg/mL glycine for 30&#xa0;min at room temperature. Subsequently, the cells were incubated overnight at 4&#xa0;&#xb0;C with primary antibodies: c-caspase3 (Cell Signaling Technology, USA) or Ki67 (Abcam, USA). The cells were then washed three times with PBST (PBS &#x2b;0.1% Tween 20) and incubated at room temperature for 1&#xa0;h with secondary antibodies: goat anti-rabbit IgG H&#x26;L (Alexa Fluor&#xae; 555) (Abcam, USA) or goat anti-rabbit IgG H&#x26;L (Alexa Fluor&#xae; 488) (Abcam, USA). The cell nuclei were stained with DAPI (Beyotime, China) for 15&#xa0;min at room temperature in the dark. Finally, images were captured using a Zeiss LSM880 confocal microscope.</p>
</sec>
<sec id="s5-11">
<label>5.11</label>
<title>Transwell indirect co-culture of human and porcine MSCs</title>
<p>Human and porcine MSCs were indirectly co-cultured in a Transwell system with 0.4&#xa0;&#x3bc;m pores. The upper chamber was seeded with hMSCs (1 &#xd7; 10<sup>4</sup>), while the lower chamber contained either hMSCs (separate culture) or pMSCs (co-culture) at varying seeding ratios. After 4&#xa0;days of culture, the proliferation of hMSCs in the upper chamber was assessed using the CCK-8 kit.</p>
</sec>
<sec id="s5-12">
<label>5.12</label>
<title>Preparation of conditioned medium from pMSCs</title>
<p>The pMSCs with 80%&#x2013;90% confluence were washed three times with PBS and cultured in serum-free medium for 24&#x2013;48&#xa0;h. The supernatant was collected and centrifuged at 300&#xa0;<italic>g</italic> for 10&#xa0;min at 4&#xa0;&#xb0;C to remove residual cells, followed by a second centrifugation at 2000&#xa0;<italic>g</italic> for 10&#xa0;min at 4&#xa0;&#xb0;C to pellet cellular debris. The solution was then filtered through a 0.22&#xa0;&#x3bc;m membrane and concentrated using a 3&#xa0;kDa Millipore ultrafiltration device by centrifugation at 4,000&#xa0;<italic>g</italic> for 40&#xa0;min at 4&#xa0;&#xb0;C. The protein concentration of the CM was quantified using the Pierce&#x2122; BCA Protein Detection Kit (Thermo, USA) and stored at &#x2212;80&#xa0;&#xb0;C for future use.</p>
</sec>
<sec id="s5-13">
<label>5.13</label>
<title>RNA sequencing</title>
<p>A total of 16 &#xd7; 10<sup>4</sup> GFP-labeled hMSCs (single-culture group) or 2.28 &#xd7; 10<sup>4</sup> GFP-labeled hMSCs combined with 13.72 &#xd7; 10<sup>4</sup> pMSCs (co-culture group) were seeded into 10&#xa0;cm culture dishes, with three replicates for each group. Once the cells reached confluence, they were digested, centrifuged at 1,000&#xa0;rpm for 5&#xa0;min, and resuspended in 800&#xa0;&#x3bc;L of FACS buffer. The suspension was then filtered through a 70&#xa0;&#x3bc;m sterile cell strainer. GFP-expressing hMSCs (5 &#xd7; 10<sup>4</sup> cells) were isolated using cell sorting, washed with PBS, and centrifuged again at 1,000&#xa0;rpm for 5&#xa0;min. The resulting cell pellet was resuspended in 400&#xa0;&#x3bc;L of TRIzol and stored at &#x2212;80&#xa0;&#xb0;C.</p>
<p>Total RNA was extracted from MSCs using TRIzol reagent (Invitrogen, USA) in accordance with the manufacturer&#x2019;s protocol. For single library preparation, the total RNA requirement was set at &#x2265;1&#xa0;&#x3bc;g, with a concentration of &#x2265;35&#xa0;ng/&#x3bc;L, an OD260/280 ratio of &#x2265;1.8, and an OD260/230 ratio of &#x2265;1.0. RNA concentration and purity were assessed using the ND-2000 spectrophotometer (NanoDrop, USA). RNA purification, reverse transcription, library preparation, and sequencing were performed following the operational guidelines (Illumina, USA). Sequence libraries underwent 2 &#xd7; 150&#xa0;bp paired-end sequencing on the Illumina NovaSeq 6,000 platform, facilitated by Cosmos Wisdom Biotech Co., Ltd. (Hangzhou, China). Raw data were filtered using fastp software to remove adapter-containing reads, trim terminal N bases, and discard low-quality reads (reads where bases with Q<sub>phred</sub> &#x2264; 20 constitute over 50% of the total read length). Alignment against the human reference genome (<italic>Homo sapiens</italic> GRCh38 release-109) was conducted using Hisat2 software. Based on the alignment results, differentially expressed genes (DEGs) were analyzed using the DESeq2 R package. Genes were identified as differentially expressed if they met the criteria of a P-value &#x2264;0.05 and an absolute fold change &#x2265;2. GO and KEGG enrichment analyses of DEGs were conducted using the cluster Profiler R package, with enrichment significance assessed using a corrected P-value &#x2264; 0.05 threshold. Finally, ggplot2 was utilized to visualize the enrichment results.</p>
</sec>
<sec id="s5-14">
<label>5.14</label>
<title>Quantitative real-time PCR</title>
<p>Total RNA was extracted from the MSCs using TRIzol (Invitrogen, USA). The purity and concentration of the RNA were determined using a NanoDrop ND-2000 spectrophotometer (Thermo, USA), with an A260/A280 ratio of 1.8&#x2013;2.0 considered acceptable. The RNA was reverse-transcribed into cDNA using RevertAid Master Mix (Thermo, USA). The validated or designed primer sets utilized are listed in <xref ref-type="table" rid="T1">Table 1</xref> qPCR was performed on a StepOnePlus&#x2122; Real-Time PCR System (Applied Biosystems, USA). Mean cycle threshold values from triplicate measurements were used to calculate gene expression using the 2<sup>&#x2212;&#x394;&#x394;Ct</sup> method, normalizing to GAPDH as the internal control.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>The primers used in the research.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Gene</th>
<th align="left">Primer sequence</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">CYP1B1 forward primer</td>
<td align="left">5&#x2032;-AAG&#x200b;TTC&#x200b;TTG&#x200b;AGG&#x200b;CAC&#x200b;TGC&#x200b;GAA-3&#x2032;</td>
</tr>
<tr>
<td align="left">CYP1B1 reverse primer</td>
<td align="left">5&#x2032;-GGC&#x200b;CGG&#x200b;TAC&#x200b;GTT&#x200b;CTC&#x200b;CAA&#x200b;AT-3&#x2032;</td>
</tr>
<tr>
<td align="left">SLC7A11 forward primer</td>
<td align="left">5&#x2032;-TCT&#x200b;CCA&#x200b;AAG&#x200b;GAG&#x200b;GTT&#x200b;ACC&#x200b;TGC-3&#x2032;</td>
</tr>
<tr>
<td align="left">SLC7A11 reverse primer</td>
<td align="left">5&#x2032;-AGA&#x200b;CTC&#x200b;CCC&#x200b;TCA&#x200b;GTA&#x200b;AAG&#x200b;TGA&#x200b;C-3&#x2032;</td>
</tr>
<tr>
<td align="left">PSAT1 forward primer</td>
<td align="left">5&#x2032;-TGC&#x200b;CGC&#x200b;ACT&#x200b;CAG&#x200b;TGT&#x200b;TGT&#x200b;TAG-3&#x2032;</td>
</tr>
<tr>
<td align="left">PSAT1 reverse primer</td>
<td align="left">5&#x2032;-GCA&#x200b;ATT&#x200b;CCC&#x200b;GCA&#x200b;CAA&#x200b;GAT&#x200b;TCT-3&#x2032;</td>
</tr>
<tr>
<td align="left">TFAP2C forward primer</td>
<td align="left">5&#x2032;-TCA&#x200b;GTC&#x200b;CCT&#x200b;GGA&#x200b;AGA&#x200b;TTG&#x200b;TCG-3&#x2032;</td>
</tr>
<tr>
<td align="left">TFAP2C reverse primer</td>
<td align="left">5&#x2032;-CCA&#x200b;GTA&#x200b;ACG&#x200b;AGG&#x200b;CAT&#x200b;TTA&#x200b;AGC&#x200b;A-3&#x2032;</td>
</tr>
<tr>
<td align="left">OCLN forward primer</td>
<td align="left">5&#x2032;-GAC&#x200b;TTC&#x200b;AGG&#x200b;CAG&#x200b;CCT&#x200b;CGT&#x200b;TAC-3&#x2032;</td>
</tr>
<tr>
<td align="left">OCLN reverse primer</td>
<td align="left">5&#x2032;-GCC&#x200b;AGT&#x200b;TGT&#x200b;GTA&#x200b;GTC&#x200b;TGT&#x200b;CTC&#x200b;A-3&#x2032;</td>
</tr>
<tr>
<td align="left">CLDN1 forward primer</td>
<td align="left">5&#x2032;-CCT&#x200b;CCT&#x200b;GGG&#x200b;AGT&#x200b;GAT&#x200b;AGC&#x200b;AAT-3&#x2032;</td>
</tr>
<tr>
<td align="left">CLDN1 reverse primer</td>
<td align="left">5&#x2032;-GGC&#x200b;AAC&#x200b;TAA&#x200b;AAT&#x200b;AGC&#x200b;CAG&#x200b;ACC&#x200b;T-3&#x2032;</td>
</tr>
<tr>
<td align="left">CLDN11 forward primer</td>
<td align="left">5&#x2032;-CAT&#x200b;TTT&#x200b;ACT&#x200b;GCT&#x200b;GCT&#x200b;GAC&#x200b;TGT&#x200b;T-3&#x2032;</td>
</tr>
<tr>
<td align="left">CLDN11 reverse primer</td>
<td align="left">5&#x2032;-CAG&#x200b;AAT&#x200b;GAG&#x200b;CAA&#x200b;AAC&#x200b;ACC&#x200b;AGC-3&#x2032;</td>
</tr>
<tr>
<td align="left">TJP1 forward primer</td>
<td align="left">5&#x2032;-CAA&#x200b;CAT&#x200b;ACA&#x200b;GTG&#x200b;ACG&#x200b;CTT&#x200b;CAC&#x200b;A-3&#x2032;</td>
</tr>
<tr>
<td align="left">TJP1 reverse primer</td>
<td align="left">5&#x2032;-CAC&#x200b;TAT&#x200b;TGA&#x200b;CGT&#x200b;TTC&#x200b;CCC&#x200b;ACT&#x200b;C-3&#x2032;</td>
</tr>
<tr>
<td align="left">CDH1 forward primer</td>
<td align="left">5&#x2032;-CGA&#x200b;GAG&#x200b;CTA&#x200b;CAC&#x200b;GTT&#x200b;CAC&#x200b;GG-3&#x2032;</td>
</tr>
<tr>
<td align="left">CDH1 reverse primer</td>
<td align="left">5&#x2032;-GGG&#x200b;TGT&#x200b;CGA&#x200b;GGG&#x200b;AAA&#x200b;AAT&#x200b;AGG-3&#x2032;</td>
</tr>
<tr>
<td align="left">CDH2 forward primer</td>
<td align="left">5&#x2032;-AGC&#x200b;CAA&#x200b;CCT&#x200b;TAA&#x200b;CTG&#x200b;AGG&#x200b;AGT-3&#x2032;</td>
</tr>
<tr>
<td align="left">CDH2 reverse primer</td>
<td align="left">5&#x2032;-GGC&#x200b;AAG&#x200b;TTG&#x200b;ATT&#x200b;GGA&#x200b;GGG&#x200b;ATG-3&#x2032;</td>
</tr>
<tr>
<td align="left">IL1B forward primer</td>
<td align="left">5&#x2032;-ATG&#x200b;ATG&#x200b;GCT&#x200b;TAT&#x200b;TAC&#x200b;AGT&#x200b;GGC&#x200b;AA-3&#x2032;</td>
</tr>
<tr>
<td align="left">IL1B reverse primer</td>
<td align="left">5&#x2032;-GTC&#x200b;GGA&#x200b;GAT&#x200b;TCG&#x200b;TAG&#x200b;CTG&#x200b;GA-3&#x2032;</td>
</tr>
<tr>
<td align="left">TNFAIP3 forward primer</td>
<td align="left">5&#x2032;-TCC&#x200b;TCA&#x200b;GGC&#x200b;TTT&#x200b;GTA&#x200b;TTT&#x200b;GAG&#x200b;C-3&#x2032;</td>
</tr>
<tr>
<td align="left">TNFAIP3 reverse primer</td>
<td align="left">5&#x2032;-TGT&#x200b;GTA&#x200b;TCG&#x200b;GTG&#x200b;CAT&#x200b;GGT&#x200b;TTT&#x200b;A-3&#x2032;</td>
</tr>
<tr>
<td align="left">GAPDH forward primer</td>
<td align="left">5&#x2032;-GGA&#x200b;GCG&#x200b;AGA&#x200b;TCC&#x200b;CTC&#x200b;CAA&#x200b;AAT-3&#x2032;</td>
</tr>
<tr>
<td align="left">GAPDH reverse primer</td>
<td align="left">5&#x2032;-GGC&#x200b;TGT&#x200b;TGT&#x200b;CAT&#x200b;ACT&#x200b;TCT&#x200b;CAT&#x200b;GG-3&#x2032;</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s5-15">
<label>5.15</label>
<title>IL-1&#x3b2; treatment in hMSCs</title>
<p>When hMSCs reached 70% confluence, 10, 20, or 40&#xa0;ng/mL of IL-1&#x3b2; (Peprotech, USA) was added into the culture medium to activate the NF-&#x3ba;B pathway. The cells were harvested for subsequent Western blot analyses at the indicated time points.</p>
</sec>
<sec id="s5-16">
<label>5.16</label>
<title>Western blot (WB)</title>
<p>Cells were lysed in EBC buffer (50&#xa0;mM Tris pH 7.5, 120&#xa0;mM NaCl, 0.5% NP-40), supplemented with protease inhibitors (Complete Mini, Roche) and phosphatase inhibitors (phosphatase inhibitor cocktail sets A and B, Biomake). Cell lysates were centrifuged at 12,000 &#xd7; g for 15&#xa0;min at 4&#xa0;&#xb0;C, and the supernatant was collected. Protein concentrations were determined using the Pierce&#x2122; BCA Protein Detection Kit (Thermo, USA). Approximately 30&#xa0;&#x3bc;g of protein was analyzed via 10% SDS-polyacrylamide gel electrophoresis. The resolved proteins were transferred onto polyvinylidene difluoride membranes, which were blocked with 5% skim milk for 1&#xa0;h at room temperature. The membranes were incubated for 12&#xa0;h with primary antibodies: anti-TNF&#x3b1; (Proteintech, China), anti-p-IKB&#x3b1; (Selleck, USA), anti-cyclinD1 and anti-PCNA (Immunoway, China) and anti-IKB&#x3b1; (Abcam, USA) (<xref ref-type="bibr" rid="B38">Su et al., 2014</xref>; <xref ref-type="bibr" rid="B2">Aierken et al., 2022</xref>; <xref ref-type="bibr" rid="B32">Qian et al., 2024</xref>; <xref ref-type="bibr" rid="B43">Zhao et al., 2025</xref>; <xref ref-type="bibr" rid="B45">Zhou et al., 2025</xref>). To avoid issues of target band overlap and interference from non-specific bands, we selected the anti-Vinculin antibody (Sigma, USA) as our internal control (<xref ref-type="bibr" rid="B41">Wenzel et al., 2024</xref>). The membranes were then washed three times with TBST (20&#xa0;mM Tris-HCl pH 7.6, 150&#xa0;mM NaCl, 0.1% Tween 20) and incubated with the corresponding secondary antibodies: goat anti-rabbit IgG H&#x26;L or goat anti-mouse IgG H&#x26;L (Abcam, USA) at room temperature for 1&#xa0;h. Signals were detected using Immobilon Western Chemiluminescent HRP Substrate (Thermo, USA) with an image analyzer.</p>
</sec>
<sec id="s5-17">
<label>5.17</label>
<title>Statistical analysis</title>
<p>All experiments were performed with at least three independent biological replicates. Values were represented as mean &#xb1; standard error of the mean (SEM). Data analysis was performed GraphPad Prism 9 statistical software. Comparisons between two groups were analyzed using <italic>t</italic>-test. <italic>P</italic> &#x3c; 0.05 was considered statistically significant, and <italic>P</italic> &#x3c; 0.01 was considered highly statistically significant.</p>
</sec>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>RNA-seq data have been deposited in the China National Center for Bioinformation - National Genomics Data Center (CNCB-NGDC) under accession number PRJCA048099.</p>
</sec>
<sec sec-type="ethics-statement" id="s7">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used. Ethical approval was not required for the studies on animals in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p>
</sec>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>XF: Investigation, Methodology, Project administration, Writing &#x2013; original draft. XA: Formal Analysis, Methodology, Writing &#x2013; review and editing. TZ: Data curation, Validation, Writing &#x2013; review and editing. ZL: Supervision, Writing &#x2013; review and editing. XD: Conceptualization, Funding acquisition, Supervision, Writing &#x2013; original draft, Writing &#x2013; review and editing. XZ: Supervision, Validation, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author XD declared that they were an editorial board member of Frontiers at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="ai-statement" id="s11">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s12">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s13">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2026.1750289/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2026.1750289/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adelipour</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lubman</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Potential applications of mesenchymal stem cells and their derived exosomes in regenerative medicine</article-title>. <source>Expert Opin. Biol. Ther.</source> <volume>23</volume> (<issue>6</issue>), <fpage>491</fpage>&#x2013;<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1080/14712598.2023.2211203</pub-id>
<pub-id pub-id-type="pmid">37147781</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aierken</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus <italic>via</italic> the PI3K/AKT signaling pathway</article-title>. <source>Stem Cell Res. and Ther.</source> <volume>13</volume> (<issue>1</issue>), <fpage>164</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-022-02832-0</pub-id>
<pub-id pub-id-type="pmid">35414044</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Dhfyan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alhoshani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Korashy</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and &#x3b2;-Catenin and akt activation</article-title>. <source>Mol. Cancer</source> <volume>16</volume> (<issue>1</issue>), <fpage>14</fpage>. <pub-id pub-id-type="doi">10.1186/s12943-016-0570-y</pub-id>
<pub-id pub-id-type="pmid">28103884</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alcolea</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Greulich</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wabik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Frede</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Simons</surname>
<given-names>B. D.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>P. H.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Differentiation imbalance in single oesophageal progenitor cells causes clonal immortalization and field change</article-title>. <source>Nat. Cell Biol.</source> <volume>16</volume> (<issue>6</issue>), <fpage>612</fpage>&#x2013;<lpage>619</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2963</pub-id>
<pub-id pub-id-type="pmid">24814514</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barcelona-Estaje</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Oliva</surname>
<given-names>M. A. G.</given-names>
</name>
<name>
<surname>Cunniffe</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rodrigo-Navarro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Genever</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dalby</surname>
<given-names>M. J.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>N-cadherin crosstalk with integrin weakens the molecular clutch in response to surface viscosity</article-title>. <source>Nat. Commun.</source> <volume>15</volume> (<issue>1</issue>), <fpage>8824</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-024-53107-6</pub-id>
<pub-id pub-id-type="pmid">39394209</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowling</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Di Gregorio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sancho</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pozzi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aarts</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Signore</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>P53 and mTOR signalling determine fitness selection through cell competition during early mouse embryonic development</article-title>. <source>Nat. Commun.</source> <volume>9</volume> (<issue>1</issue>), <fpage>1763</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-04167-y</pub-id>
<pub-id pub-id-type="pmid">29720666</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chazaud</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Lineage specification in the mouse preimplantation embryo</article-title>. <source>Development</source> <volume>143</volume> (<issue>7</issue>), <fpage>1063</fpage>&#x2013;<lpage>1074</lpage>. <pub-id pub-id-type="doi">10.1242/dev.128314</pub-id>
<pub-id pub-id-type="pmid">27048685</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Comite</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cobianchi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Avanzini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mantelli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Achille</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Zonta</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Immunomodulatory properties of porcine, bone marrow-derived multipotent mesenchymal stromal cells and comparison with their human counterpart</article-title>. <source>Cell Mol. Biol. (Noisy-le-grand)</source> <volume>57</volume> (<issue>5</issue>), <fpage>OL1600</fpage>&#x2013;<lpage>OL1605</lpage>. <pub-id pub-id-type="doi">10.1170/185</pub-id>
<pub-id pub-id-type="pmid">22000490</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Koyano-Nakagawa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gafni</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Maeng</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>B. N.</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Generation of human endothelium in pig embryos deficient in ETV2</article-title>. <source>Nat. Biotechnol.</source> <volume>38</volume> (<issue>3</issue>), <fpage>297</fpage>&#x2013;<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1038/s41587-019-0373-y</pub-id>
<pub-id pub-id-type="pmid">32094659</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de la Cova</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Senoo-Matsuda</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ziosi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Bellosta</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Quinzii</surname>
<given-names>C. M.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Supercompetitor status of drosophila myc cells requires p53 as a fitness sensor to reprogram metabolism and promote viability</article-title>. <source>Cell Metab.</source> <volume>19</volume> (<issue>3</issue>), <fpage>470</fpage>&#x2013;<lpage>483</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2014.01.012</pub-id>
<pub-id pub-id-type="pmid">24561262</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edward</surname>
<given-names>R. O.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Susan A</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Glaser</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Ribosomal protein L24 defect in belly spot and tail (bst), a mouse minute</article-title>. <source>Development</source> <volume>131</volume> (<issue>16</issue>), <fpage>3907</fpage>&#x2013;<lpage>3920</lpage>. <pub-id pub-id-type="doi">10.1242/dev.01268</pub-id>
<pub-id pub-id-type="pmid">15289434</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fantone</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Piani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Olivieri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rippo</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Sirico</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Di Simone</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Role of SLC7A11/xCT in ovarian cancer</article-title>. <source>Int. J. Mol. Sci.</source> <volume>25</volume> (<issue>1</issue>), <fpage>587</fpage>. <pub-id pub-id-type="doi">10.3390/ijms25010587</pub-id>
<pub-id pub-id-type="pmid">38203758</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gines</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ripoll</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1975</year>). <article-title>Minutes: mutants of drosophila autonomously affecting cell division rate</article-title>. <source>Dev. Biol.</source> <volume>42</volume> (<issue>2</issue>), <fpage>211</fpage>&#x2013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1016/0012-1606(75)90330-9</pub-id>
<pub-id pub-id-type="pmid">1116643</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Mesenchymal stem cells for regenerative medicine</article-title>. <source>Cells</source> <volume>8</volume> (<issue>8</issue>). <pub-id pub-id-type="doi">10.3390/cells8080886</pub-id>
<pub-id pub-id-type="pmid">31412678</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashimoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Epiblast formation by TEAD-YAP-Dependent expression of pluripotency factors and competitive elimination of unspecified cells</article-title>. <source>Dev. Cell</source> <volume>50</volume> (<issue>2</issue>), <fpage>139</fpage>&#x2013;<lpage>154.e135</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2019.05.024</pub-id>
<pub-id pub-id-type="pmid">31204175</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H.-X.</given-names>
</name>
<name>
<surname>Sakurai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>RNA innate immunity constitutes a barrier for interspecies chimerism</article-title>. <source>Cell</source> <volume>189</volume>, <fpage>23</fpage>&#x2013;<lpage>33.e16</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2025.10.039</pub-id>
<pub-id pub-id-type="pmid">41289993</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yeung</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Developmental potency of human ES cell-derived mesenchymal stem cells revealed in mouse embryos following blastocyst injection</article-title>. <source>Cell Rep.</source> <volume>42</volume> (<issue>12</issue>), <fpage>113459</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2023.113459</pub-id>
<pub-id pub-id-type="pmid">37988266</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Javedan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shidfar</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Davoodi</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Ajami</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gorjipour</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sureda</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Conjugated linoleic acid rat pretreatment reduces renal damage in ischemia/reperfusion injury: unraveling antiapoptotic mechanisms and regulation of phosphorylated Mammalian target of rapamycin</article-title>. <source>Mol. Nutr. and Food Res.</source> <volume>60</volume> (<issue>12</issue>), <fpage>2665</fpage>&#x2013;<lpage>2677</lpage>. <pub-id pub-id-type="doi">10.1002/mnfr.201600112</pub-id>
<pub-id pub-id-type="pmid">27466783</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>TFAP2C promotes lung tumorigenesis and aggressiveness through miR-183- and miR-33a-mediated cell cycle regulation</article-title>. <source>Oncogene</source> <volume>36</volume> (<issue>11</issue>), <fpage>1585</fpage>&#x2013;<lpage>1596</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2016.328</pub-id>
<pub-id pub-id-type="pmid">27593936</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khandekar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>S. J.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>An expanded view of cell competition</article-title>. <source>Development</source> <volume>151</volume> (<issue>22</issue>), <fpage>dev204212</fpage>. <pub-id pub-id-type="doi">10.1242/dev.204212</pub-id>
<pub-id pub-id-type="pmid">39560103</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ishibashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Katoh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kitamoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shirai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Cell competition with normal epithelial cells promotes apical extrusion of transformed cells through metabolic changes</article-title>. <source>Nat. Cell Biol.</source> <volume>19</volume> (<issue>5</issue>), <fpage>530</fpage>&#x2013;<lpage>541</lpage>. <pub-id pub-id-type="doi">10.1038/ncb3509</pub-id>
<pub-id pub-id-type="pmid">28414314</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Porcine endogenous retrovirus: classification, molecular structure, regulation, function, and potential risk in xenotransplantation</article-title>. <source>Funct. and Integr. Genomics</source> <volume>23</volume> (<issue>1</issue>), <fpage>60</fpage>. <pub-id pub-id-type="doi">10.1007/s10142-023-00984-7</pub-id>
<pub-id pub-id-type="pmid">36790562</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>PSAT1 inhibits mTORC1 activation by preventing rag heterodimer formation in lung adenocarcinoma</article-title>. <source>Autophagy</source>, <fpage>1</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2025.2535765</pub-id>
<pub-id pub-id-type="pmid">40702660</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maeng</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Greising</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>B. N.</given-names>
</name>
<name>
<surname>Kren</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Humanized skeletal muscle in MYF5/MYOD/MYF6-null pig embryos</article-title>. <source>Nat. Biomed. Eng.</source> <volume>5</volume> (<issue>8</issue>), <fpage>805</fpage>&#x2013;<lpage>814</lpage>. <pub-id pub-id-type="doi">10.1038/s41551-021-00693-1</pub-id>
<pub-id pub-id-type="pmid">33782573</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mallapaty</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Tiny human hearts grown in pig embryos for the first time</article-title>. <source>Nature</source> <volume>642</volume> (<issue>8069</issue>), <fpage>852</fpage>. <pub-id pub-id-type="doi">10.1038/D41586-025-01854-X</pub-id>
<pub-id pub-id-type="pmid">40514527</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marques-Reis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Role of cell competition in ageing</article-title>. <source>Dev. Biol.</source> <volume>476</volume>, <fpage>79</fpage>&#x2013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2021.03.009</pub-id>
<pub-id pub-id-type="pmid">33753080</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Amoyel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Berganti&#xf1;os</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>de la Cova</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schertel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Basler</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>An ancient defense system eliminates unfit cells from developing tissues during cell competition</article-title>. <source>Science</source> <volume>346</volume> (<issue>6214</issue>). <pub-id pub-id-type="doi">10.1126/science.1258236</pub-id>
<pub-id pub-id-type="pmid">25477468</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Porcine genome engineering for xenotransplantation</article-title>. <source>Adv. Drug Deliv. Rev.</source> <volume>168</volume>, <fpage>229</fpage>&#x2013;<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2020.04.001</pub-id>
<pub-id pub-id-type="pmid">32275950</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noort</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>Oerlemans</surname>
<given-names>M. I. F. J.</given-names>
</name>
<name>
<surname>Rozemuller</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Feyen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jaksani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stecher</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Human <italic>versus</italic> porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation</article-title>. <source>J. Cell. Mol. Med.</source> <volume>16</volume> (<issue>8</issue>), <fpage>1827</fpage>&#x2013;<lpage>1839</lpage>. <pub-id pub-id-type="doi">10.1111/j.1582-4934.2011.01455.x</pub-id>
<pub-id pub-id-type="pmid">21973026</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nowlan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Futrega</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>E. D.</given-names>
</name>
<name>
<surname>Doran</surname>
<given-names>M. R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Human bone marrow-derived stromal cell behavior when injected directly into the bone marrow of NOD-scid-gamma mice pre-conditioned with sub-lethal irradiation</article-title>. <source>Stem Cell Res. and Ther.</source> <volume>12</volume> (<issue>1</issue>), <fpage>231</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-021-02297-7</pub-id>
<pub-id pub-id-type="pmid">33845908</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plusa</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Piliszek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Frankenberg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Artus</surname>
<given-names>J. r.m.</given-names>
</name>
<name>
<surname>Hadjantonakis</surname>
<given-names>A.-K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Distinct sequential cell behaviours direct primitive endoderm formation in the mouse blastocyst</article-title>. <source>Development</source> <volume>135</volume> (<issue>18</issue>), <fpage>3081</fpage>&#x2013;<lpage>3091</lpage>. <pub-id pub-id-type="doi">10.1242/dev.021519</pub-id>
<pub-id pub-id-type="pmid">18725515</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qian</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Coiled&#x2010;coil domain containing 25 (CCDC25) regulates cell proliferation, migration, and invasion in clear cell renal cell carcinoma by targeting the ILK&#x2010;NF&#x2010;&#x3ba;B signaling pathway</article-title>. <source>FASEB J.</source> <volume>38</volume> (<issue>2</issue>), <fpage>e23414</fpage>. <pub-id pub-id-type="doi">10.1096/fj.202301064RR</pub-id>
<pub-id pub-id-type="pmid">38236371</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodrigues</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Zoranovic</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ayala-Camargo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grewal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Reyes-Robles</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Krasny</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Activated STAT regulates growth and induces competitive interactions independently of myc, yorkie, wingless and ribosome biogenesis</article-title>. <source>Development</source> <volume>139</volume> (<issue>21</issue>), <fpage>4051</fpage>&#x2013;<lpage>4061</lpage>. <pub-id pub-id-type="doi">10.1242/dev.076760</pub-id>
<pub-id pub-id-type="pmid">22992954</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sander</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Calado</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Srinivasan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>K&#xf6;chert</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rosolowski</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Synergy between PI3K signaling and MYC in burkitt lymphomagenesis</article-title>. <source>Cancer Cell</source> <volume>22</volume> (<issue>2</issue>), <fpage>167</fpage>&#x2013;<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2012.06.012</pub-id>
<pub-id pub-id-type="pmid">22897848</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schuurman</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Pathology of xenograft rejection: a commentary</article-title>. <source>Xenotransplantation</source> <volume>10</volume> (<issue>4</issue>), <fpage>293</fpage>&#x2013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1034/j.1399-3089.2003.02092.x</pub-id>
<pub-id pub-id-type="pmid">12795678</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skamrahl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ferle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gottwald</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>R&#xfc;beling</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Maraspini</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Tight junction ZO proteins maintain tissue fluidity, ensuring efficient collective cell migration</article-title>. <source>Adv. Sci.</source> <volume>8</volume> (<issue>19</issue>), <fpage>e2100478</fpage>. <pub-id pub-id-type="doi">10.1002/advs.202100478</pub-id>
<pub-id pub-id-type="pmid">34382375</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith-Berdan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hassanein</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zimmer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ugarte</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ciriza</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Robo4 cooperates with Cxcr4 to specify hematopoietic stem cell localization to bone marrow niches</article-title>. <source>Cell Stem Cell</source> <volume>8</volume> (<issue>1</issue>), <fpage>72</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2010.11.030</pub-id>
<pub-id pub-id-type="pmid">21211783</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>The transcription factor FOXO4 is down-regulated and inhibits tumor proliferation and metastasis in gastric cancer</article-title>. <source>BMC Cancer</source> <volume>14</volume>, <fpage>378</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2407-14-378</pub-id>
<pub-id pub-id-type="pmid">24886657</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Neerven</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Vermeulen</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Cell competition in development, homeostasis and cancer</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>24</volume> (<issue>3</issue>), <fpage>221</fpage>&#x2013;<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-022-00538-y</pub-id>
<pub-id pub-id-type="pmid">36175766</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Generation of a humanized mesonephros in pigs from induced pluripotent stem cells <italic>via</italic> embryo complementation</article-title>. <source>Cell Stem Cell</source> <volume>30</volume> (<issue>9</issue>), <fpage>1235</fpage>&#x2013;<lpage>1245.e1236</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2023.08.003</pub-id>
<pub-id pub-id-type="pmid">37683604</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wenzel</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Elfmark</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kjos</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Stang</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Intercellular transfer of cancer cell invasiveness <italic>via</italic> endosome-mediated protease shedding</article-title>. <source>Nat. Commun.</source> <volume>15</volume> (<issue>1</issue>), <fpage>1277</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-024-45558-8</pub-id>
<pub-id pub-id-type="pmid">38341434</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Platero-Luengo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sakurai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sugawara</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gil</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Yamauchi</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Interspecies chimerism with mammalian pluripotent stem cells</article-title>. <source>Cell</source> <volume>168</volume> (<issue>3</issue>), <fpage>473</fpage>&#x2013;<lpage>486.e415</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.12.036</pub-id>
<pub-id pub-id-type="pmid">28129541</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Deliver CEBPE <italic>via</italic> cartilage targeting lipid nanoparticle to block CEBPE-LTF-STAT3 positive feedback loop for efficient treatment of cartilage endplate degeneration</article-title>. <source>Mater. Today Bio</source> <volume>33</volume>, <fpage>102027</fpage>. <pub-id pub-id-type="doi">10.1016/j.mtbio.2025.102027</pub-id>
<pub-id pub-id-type="pmid">40677394</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sakurai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pinzon-Arteaga</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Cell competition constitutes a barrier for interspecies chimerism</article-title>. <source>Nature</source> <volume>592</volume> (<issue>7853</issue>), <fpage>272</fpage>&#x2013;<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03273-0</pub-id>
<pub-id pub-id-type="pmid">33508854</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>ERR&#x3b3; promotes multiple myeloma survival by coordinating NF-&#x3ba;B signaling and mitochondrial apoptosis regulation</article-title>. <source>Oncol. Res.</source> <volume>33</volume> (<issue>9</issue>), <fpage>2399</fpage>&#x2013;<lpage>2420</lpage>. <pub-id pub-id-type="doi">10.32604/or.2025.063700</pub-id>
<pub-id pub-id-type="pmid">40918468</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1625899/overview">Bhanu Telugu</ext-link>, University of Missouri, United States</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1044367/overview">Hamidreza Pazoki-Toroudi</ext-link>, Iran University of Medical Sciences, Iran</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2167892/overview">Julia Metzger</ext-link>, University of Veterinary Medicine Hannover, Germany</p>
</fn>
</fn-group>
</back>
</article>